MCID: HDR003
MIFTS: 45

Hidradenitis malady

Category: Skin diseases

Aliases & Classifications for Hidradenitis

About this section

Aliases & Descriptions for Hidradenitis:

Name: Hidradenitis 11 39 13 68
 
Hydradenitis 11

Classifications:



External Ids:

Disease Ontology11 DOID:2282
ICD9CM32 705.83
MeSH39 D016575
NCIt45 C112190

Summaries for Hidradenitis

About this section
Wikipedia:71 Hidradenitis is any disease in which the histologic abnormality is primarily an inflammatory infiltrate... more...

MalaCards based summary: Hidradenitis, also known as hydradenitis, is related to squamous cell carcinoma and hidradenitis suppurativa. An important gene associated with Hidradenitis is NCSTN (Nicastrin), and among its related pathways are Development and heterogeneity of the ILC family and Notch Pathway. Affiliated tissues include neutrophil, skin and myeloid, and related mouse phenotypes are craniofacial and digestive/alimentary.

Related Diseases for Hidradenitis

About this section

Diseases related to Hidradenitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 123)
idRelated DiseaseScoreTop Affiliating Genes
1squamous cell carcinoma30.3KRT10, KRT14
2hidradenitis suppurativa12.5
3pyoderma gangrenosum-acne-suppurative hidradenitis syndrome11.8
4acne inversa, familial, 111.0
5perifolliculitis capitis abscedens et suffodiens, familial10.8
6acne inversa, familial, 310.8
7acne inversa, familial, 210.8
8acne10.4
9dermatosis papulosa nigra10.2NOD2, TNF
10amyotrophic lateral sclerosis type 510.2NOD2, TNF
11psoriatic arthritis10.2NOD2, TNF
12stomach carcinoma in situ10.2NCSTN, PSENEN
13odontogenic myxoma10.2IL17A, NOD2
14dermatitis herpetiformis10.2IL17A, TNF
15amyotrophic lateral sclerosis type 1410.2NOD2, TNF
16intermediate malignant teratoma10.2NCSTN, PSEN1, PSENEN
17aniseikonia10.2IL17A, TNF
18meier-gorlin syndrome 310.1NOD2, TNF
19pick disease10.1DSG2, PSEN1
20nemaline myopathy 1, autosomal dominant or recessive10.1NCSTN, PSENEN, TNF
21crohn's disease10.1
22juvenile amyotrophic lateral sclerosis with dementia10.1DSG2, TNF
23pyoderma10.1
24pyoderma gangrenosum10.1
25scleroperikeratitis10.1KRT14, NCSTN, PSENEN
26ebola hemorrhagic fever10.1KRT10, KRT14
27trichomalacia10.1IL17A, TNF
28anal margin basal cell carcinoma10.1KRT10, KRT14
29mixed cell adenoma10.1KRT10, KRT14
30histiocytoma10.1NOD2, TNF
31dowling-degos disease 110.1KRT10, KRT14
32parkinson disease 1110.1IL17A, NOD2, TNF
33gastric dilatation10.0IL17A, TNF
34crohn's colitis10.0IL17A, NOD2, TNF
35celiac disease10.0IL17A, NOD2, TNF
36endobronchial leiomyoma10.0IL17A, NOD2, TNF
37uterine ligament clear cell adenocarcinoma10.0IL17A, NOD2, TNF
38esophageal candidiasis10.0IL17A, NOD2, TNF
39basaloid squamous cell carcinoma10.0KRT10, KRT14
40molybdenum cofactor deficiency a10.0IL17A, NOD2, TNF
41childhood malignant hemangiopericytoma10.0IL17A, NOD2, TNF
42collagenous colitis10.0IL17A, NOD2, TNF
43thymus mucoepidermoid carcinoma10.0IL17A, KRT10
44substance-induced psychosis10.0IL17A, PSEN1, TNF
45epidermolysis bullosa10.0IL17A, NOD2, TNF
46epithelioid type angiomyolipoma10.0IL17A, PSEN1, TNF
47malignant histiocytosis10.0NOD2, TNF
48pigmented nodular adrenocortical disease, primary, 410.0IL12RB1, NOD2
49acute kidney failure10.0NCSTN, PSEN1, PSENEN, TNF
50glycogen storage disease ix10.0IL17A, NOD2, TNF

Graphical network of the top 20 diseases related to Hidradenitis:



Diseases related to hidradenitis

Symptoms & Phenotypes for Hidradenitis

About this section

MGI Mouse Phenotypes related to Hidradenitis according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053829.4IL17A, KRT14, NCSTN, PSEN1, TNF
2MP:00053819.2IL17A, KRT14, NOD2, PSEN1, TNF
3MP:00053978.1IL12RB1, IL17A, KRT14, NCSTN, NOD2, PSEN1
4MP:00053878.0IL12RB1, IL17A, KRT14, NCSTN, NOD2, PSEN1
5MP:00107687.2DSG2, IL17A, KRT14, NCSTN, NOD2, PSEN1

Drugs & Therapeutics for Hidradenitis

About this section

Drugs for Hidradenitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 68)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
AdalimumabapprovedPhase 4, Phase 3, Phase 2494331731-18-116219006
Synonyms:
331731-18-1
Adalimumab
Adalimumab (USAN/INN)
Adalimumab (genetical recombination)
 
Adalimumab (genetical recombination) (JAN)
D02597
Humira
Humira (TN)
Humira Pen
Ig gamma-1 chain C region
2Anti-Inflammatory AgentsPhase 4, Phase 3, Phase 210729
3Antirheumatic AgentsPhase 4, Phase 3, Phase 210956
4Antibiotics, AntitubercularPhase 37180
5Anti-Bacterial AgentsPhase 3, Phase 211226
6
InfliximabapprovedPhase 2392170277-31-3
Synonyms:
 
Ig gamma-1 chain C region
Remicade
7
Ustekinumabapproved, investigationalPhase 288815610-63-0
Synonyms:
 
Stelera
8
Etanerceptapproved, investigationalPhase 2403185243-69-0
Synonyms:
185243-69-0
CD120b
D00742
Enbrel
Enbrel (TN)
Enbrel Sureclick
Etanercept
Etanercept (USAN/INN)
 
Etanercept (genetical recombination)
Etanercept (genetical recombination) (JAN)
TNF-R2
Tumor necrosis factor receptor 2
Tumor necrosis factor receptor superfamily member 1B precursor
Tumor necrosis factor receptor type II
etanercept
p75
p80 TNF-alpha receptor
9
Apremilastapproved, investigationalPhase 275608141-41-911561674
Synonyms:
Apremilast
Apremilast (USAN)
Apremilastum
Aprémilast
CC-10004
 
CHEBI:558773
CHEMBL514800
CID11561674
D08860
N-[2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methylsulfonyl-ethyl]-1,3-dioxo-isoindol-4-yl]acetamide
N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide
10
Ethinyl EstradiolapprovedPhase 272857-63-65991
Synonyms:
17 alpha-Ethinylestradiol
17 alpha-Ethynylestradiol
17 alpha-Ethynyloestradiol
17 alpha-ethinyestradiol
17-Ethinyl-3,17-estradiol
17-Ethinyl-3,17-oestradiol
17-Ethinylestradiol
17-Ethynylestradiol
17-Ethynylestradiol ram
17-Ethynyloestradiol
17-alpha-Ethinyl-17-beta-estradiol
17-alpha-Ethynyl-17-beta-oestradiol
17-alpha-Ethynylestradiol
17-alpha-Ethynylestradiol-17-beta
17-alpha-ethynyl estradiol
17-ethinyl-3,17-estradiol
17-ethinyl-3,17-oestradiol
17-ethinylestradiol
17.alpha.-Ethinyl-17.beta.-estradiol
17.alpha.-Ethinylestradiol
17.alpha.-Ethynyl-17.beta.-oestradiol
17.alpha.-Ethynylestradiol
17.alpha.-Ethynylestradiol-l7.beta.
17.alpha.-Ethynyloestradiol
17.alpha.-Ethynyloestradiol-17.beta.
17a-Ethinyl-17b-estradiol
17a-Ethinylestradiol
17a-Ethynyl-17b-oestradiol
17a-Ethynylestradiol
17a-Ethynylestradiol-l7b
17a-Ethynyloestradiol
17a-Ethynyloestradiol-17b
17alpha-Ethinyl estradiol
17alpha-Ethinylestradiol
17alpha-Ethinylestradiol-17beta
17alpha-Ethynylestradiol
17alpha-Ethynyloestradiol
17alpha-Ethynyloestradiol-17beta
17α-ethynylestradiol
406932-93-2
46263_FLUKA
46263_RIEDEL
57-63-6
77538-56-8
AC-2169
AC1L1LK6
AI3-52941
Aethinyloestradiolum
Aethinyoestradiol
Aethinyoestradiol [German]
Alora
Amenoron
Amenorone
Anovlar
BIDD:ER0162
BRN 2419975
Bio-0610
C07534
CCRIS 286
CHEBI:4903
CHEMBL691
CID5991
CPD000058319
Certostat
Chee-O-Gen
Chee-O-Genf
Cyclosa
D004997
D00554
DB00977
Dicromil
Diognat-E
Diogyn E
Diogyn-E
Diprol
Dyloform
E4876_SIGMA
EE
EE(sub 2)
EE2
EINECS 200-342-2
EO
ETHINYLESTRADIOL
Effik Brand of Ethinyl Estradiol
Ertonyl
Esclim
Esteed
Estigyn
Estinyl
Estinyl (TN)
Eston-E
Estopherol
Estoral
Estoral (Orion)
Estoral (VAN)
Estoral [Orion]
Estoral {[Orion]}
Estorals
Estradiol, Ethinyl
Estradiol, Ethynyl
Estring
Estrogen
Ethidol
Ethinoral
Ethinyl E2
Ethinyl Estradiol Hemihydrate
Ethinyl Estradiol [USP]
 
Ethinyl Estradiol, (8 alpha)-Isomer
Ethinyl Oestradiol Effik
Ethinyl estradiol
Ethinyl estradiol (USP)
Ethinyl-Oestradiol Effik
Ethinyl-Oestranol
Ethinyl-oestranol
Ethinylestradiol
Ethinylestradiol (JP15/INN)
Ethinylestradiol Jenapharm
Ethinylestradiol [INN:BAN:JAN]
Ethinylestradiolum
Ethinylestradiolum [INN-Latin]
Ethinylestriol
Ethinyloestradiol
Ethinyloestradiol [Steroidal oestrogens]
Ethy 11
Ethynyl estradiol
Ethynylestradiol
Ethynylestradiol, Ethinyl Estradiol
Ethynyloestradiol
Eticyclin
Eticyclol
Eticylol
Etinestrol
Etinestryl
Etinilestradiol
Etinilestradiol [INN-Spanish]
Etinilestradiolo
Etinilestradiolo [DCIT]
Etinoestryl
Etistradiol
Etivex
Evra
Feminone
Fempatch
Follicoral
Ginestrene
Gynodiol
Gynolett
HMS2051I19
HSDB 3587
Halodrin
Hemihydrate, Ethinyl Estradiol
Inestra
Innofem
Jenapharm Brand of Ethinyl Estradiol
Jenapharm, Ethinylestradiol
Kolpolyn
LMST02010036
LS-231
Linoral
Lynoral
MLS000028479
MLS000758274
Marvelon
Menolyn
Menostar
Mercilon
Microfollin
Microfollin Forte
MolPort-001-794-636
NCGC00091533-01
NCGC00091533-04
NCGC00091533-05
NCI60_000234
NSC-10973
NSC10973
Neo-Estrone
Nogest-S
Novestrol
OVULEN-21
OVULEN-28
Oradiol
Orestralyn
Orestrayln
Organon Brand of Ethinyl Estradiol
Ortho-Cyclen
Ovex
Oviol
PUBERTAL ETHINYL ESTRADIOL STUDY
Palonyl
Perovex
Primogyn
Primogyn C
Primogyn M
Progynon C
Progynon M
Prosexol
S1625_Selleck
SAM001247008
SGCUT00127
SMR000058319
Schering Brand of Ethinyl Estradiol
Spanestrin
Thiuram E
Thiuranide
UNII-423D2T571U
Vagifem
Varnoline
WLN: L E5 B666TTT&J E1 FQ F1UU1 OQ
Ylestrol
component of Demulen
component of Oracon
component of Ortrel
ethinyl estradiol
ethynyl estradiol
to_000048
11
Estradiolapproved, investigational, vet_approvedPhase 2131850-28-25757, 53477783
Synonyms:
(+)-3,17b-Estradiol
(17b)-Estra-1,3,5(10)-triene-3,17-diol
(17beta)-Estra-1,3,5(10)-triene-3,17-diol
.alpha.-Estradiol
.alpha.-Oestradiol
.beta.-Estradiol
.beta.-Oestradiol
1,3,5[10]-Estratriene-3,17beta-diol 3-sulfate
1,3,5[10]-Estratriene-3,17beta-diol 3-sulphate
13b-Methyl-1,3,5(10)-gonatriene-3,17b-ol
17 beta-Estradiol
17-.BETA.-Estradiol
17-E
17-beta
17-beta-OH-estradiol
17-beta-estradiol
17.beta.-Estradiol
17.beta.-Oestradiol
17E
17b-Estradiol
17b-Oestradiol
17beta Oestradiol
17beta oestradiol
17beta-Estra-1,3,5(10)-triene-3,17-diol
17beta-Estradiol
17beta-Oestradiol
1jgl
1qkt
1qku
2d06
3,17-Epidihydroxyestratriene
3,17-beta-Estradiol
3,17-beta-Oestradiol
3,17.beta.-Estradiol
3,17b-Dihydroxyestra-1,3,5(10)-triene
3,17b-Estradiol
3,17beta-Estradiol
3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulfate
3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulphate
50-28-2
73459-61-7
873662-39-6
AC-10460
AC1L1L2K
Aerodiol
Agofollin
Alora
Altrad
Amnestrogen
Aquadiol
B-Estradiol
BEDOs
BIDD:ER0125
BIDD:PXR0065
BPBio1_000532
BSPBio_000482
BSPBio_001065
Bardiol
Benzhormovarine
Beta-estradiol
Bio-0812
Bio-E-Gel
Bio1_000403
Bio1_000892
Bio1_001381
Bio2_000363
Bio2_000843
C00951
C18H24O2
CCRIS 280
CHEBI:16469
CHEMBL135
CID5757
CMC_11154
CPD-352
CPD000059126
Climaderm
Climara
Climara (TN)
Climara Forte
Compudose
Compudose 200
Compudose 365
Corpagen
D-3,17beta-Estradiol
D-Estradiol
D-Oestradiol
D00105
DB00783
Dermestril
Destradiol
Dihydro-Theelin
Dihydrofollicular hormone
Dihydrofolliculin
Dihydromenformon
Dihydrotheelin
Dihydroxyesterin
Dihydroxyestrin
Dihydroxyoestrin
Dimenformon
Diogyn
Diogynets
Divigel
Divigel (TN)
E 2
E 8875
E(sub 2)
E0025
E1024_SIGMA
E1132_SIGMA
E2257_SIGMA
E2758_SIGMA
E8875_SIGMA
EINECS 200-023-8
EU-0100503
Elestrin
Encore
Epiestriol 50
Esclim
Estra-1,3,5(10)-triene-3,17b-diol
Estrace
Estrace (TN)
Estraderm
Estraderm (TN)
Estraderm MX
Estraderm TTS
Estraderm TTS 100
Estraderm TTS 50
Estradiol
Estradiol [USAN:INN]
Estradiol-17 beta
Estradiol-17-beta
Estradiol-17.beta.
Estradiol-17beta
Estradiol-3,17beta
Estradiolo
Estradiolo [DCIT]
Estradiolum
Estradiolum [INN]
Estradot
Estraldine
Estrapak 50
Estrasorb
Estrasorb (TN)
Estreva
Estrifam
Estring
Estring (TN)
Estring Vaginal Ring
Estring vaginal ring
Estroclim
Estroclim 50
Estrodiolum
Estrofem 2
Estrofem Forte
Estrogel
 
Estrogel (TN)
Estrogel HBF
Estrovite
Evamist
Evorel
Extrasorb
Femanest
Femestral
Femestrol
Femogen
Fempatch
Femtrace
Femtran
Follicyclin
Gelestra
Ginedisc
Ginosedol
GynPolar
Gynergon
Gynestrel
Gynodiol
Gynoestryl
HMS1362E07
HMS1569I04
HMS1792E07
HMS1990E07
HMS2051C17
HMS2090E18
HSDB 3589
IDI1_002118
Innofem
Innofem (TN)
KBio2_000405
KBio2_002269
KBio2_002973
KBio2_004837
KBio2_005541
KBio2_007405
KBio3_000769
KBio3_000770
KBio3_002749
KBioGR_000405
KBioGR_002269
KBioSS_000405
KBioSS_002270
LMST02010001
LS-137
Lamdiol
Lio-Oid
Lopac0_000503
MLS000069494
MLS000758312
MLS001076331
Macrodiol
Macrol
Menest
Menorest
Menostar
Microdiol
MolPort-001-794-632
NCGC00091544-00
NCGC00091544-01
NCGC00091544-02
NCGC00091544-04
NCGC00091544-05
NCGC00091544-06
NCGC00091544-07
NCGC00091544-08
NCGC00091544-09
NCGC00091544-12
NCGC00179321-01
NCGC00179321-02
NSC-9895
NSC9895
Nordicol
Oesclim
Oestergon
Oestra-1,3,5(10)-triene-3,17b-diol
Oestradiol
Oestradiol Berco
Oestradiol R
Oestradiol-17-beta
Oestradiol-17.beta.
Oestradiol-17beta
Oestradiolum
Oestrogel
Oestroglandol
Oestrogynal
Ovahormon
Ovasterol
Ovastevol
Ovociclina
Ovocyclin
Ovocycline
Ovocylin
Perlatanol
Polyestradiol
Prestwick0_000441
Prestwick1_000441
Prestwick2_000441
Prestwick3_000441
Prestwick_207
Primofol
Profoliol
Profoliol B
Progynon
Progynon DH
Progynon-DH
S-21400
S1709_Selleck
SAM001247032
SK-Estrogens
SL-1100
SMP1_000121
SMR000059126
SPBio_002421
Sandrena 1
Sandrena Gel
Sisare Gel
Spectrum5_002055
Syndiol
Systen
Tradelia
Trial SAT
Trocosone
UNII-4TI98Z838E
VIVELLE-DOT
Vagifem
Vagifem (TN)
Vivelle
Vivelle (TN)
Zerella
Zesteem
Zesteen
Zumenon
[2,4,6,7-3H]-E2
[3H]-estradiol
[3H]]estradiol
b-Estradiol
beta-Estradiol
beta-Estradiol 3-sulfate
beta-Estradiol 3-sulphate
bmse000642
cMAP_000005
cis-Estradiol
cis-Oestradiol
component of Menrium
delta-Estradiol
delta-Oestradiol
estradiol
estradiol-17beta
nchembio.168-comp3
nchembio.76-comp2
nchembio775-comp2
nchembio794-comp6
nchembio860-comp1
progynon
12
DrospirenoneapprovedPhase 210967392-87-468873
Synonyms:
(6R,7R,8R,9S,10R,13S,14S,15S,16S,17S)-1,3',4',6,6a,7,8,9,10,11,12,13,14,15,15a,16-Hexadecahydro-10,13-dimethylspiro-(17H-dicyclopropa(6,7:15,16)cyclopenta(a)phenanthrene-17,2'(5'H)-furan)-3,5'(2H)-dione
1, 2-Dihydrospirorenone
1,2-Dihydrospirorenone
1,2-dihydro-spirorenone
15,16]-17alpha-pregn-4-ene-21,17-carbolactone
15-beta,16-beta-Dimethylene-3-oxo-17-alpha-pregn-4-ene-21,17-carbolactone
15beta,16beta-Dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone
15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone
17-Hydroxy-6beta,7beta:15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21-carboxylic acid, gamma-lactone
3-oxo-6alpha,7alpha,15alpha,16alpha-tetrahydro-7'H,16'H-dicyclopropa[6,7
6-beta,7-beta
67392-87-4
6beta,7Beta
6beta,7beta
6beta,7beta,15beta,16beta-dimethylen-3-oxo-17alpha-pregn-4-en-21,17-carbolacton
6beta,7beta,15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17 carbolactone
6β,7β,15β,16β-dimethylene-3-oxo-17α-pregn-4-ene-21,17 carbolactone
AC1L2AMM
Angeliq, Drospirenone
BRN 4765500
C035144
C24H30O3
CCRIS 6523
CHEBI:50838
 
CHEMBL1509
CID68873
D03917
DB01395
DRSP
Dehydrospirorenone
Dihydrospirorenone
Drospirenona
Drospirenona [INN-Spanish]
Drospirenona [inn-spanish]
Drospirenone
Drospirenone (JAN/USAN/INN)
Drospirenone [INN]
Drospirenonum
Drospirenonum [INN-Latin]
Drospirenonum [inn-latin]
EINECS 266-679-2
LS-146115
S1377_Selleck
SH-470
Spiro(17H-dicyclopropa(6,7:15,16)cyclopenta(a)phenanthrene-17,2'(5'H)-furan)-3,5'(2H)-dione, 1,3',4',6,7,8,9,10,11,12,13,14,15,16,20,21-hexadecahydro-10,13-dimethyl-, (6R-(6alpha,7alpha,8beta,9alpha,10beta,13beta,14alpha,15alpha,16alpha,17beta
UNII-N295J34A25
ZINC03927200
ZK 30595
ZK-30595
ZK30595
13Anti-Infective AgentsPhase 2, Phase 122062
14Dermatologic AgentsPhase 25806
15Immunosuppressive AgentsPhase 213086
16Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 213168
17HormonesPhase 214415
18Hormone AntagonistsPhase 213180
19ImmunoglobulinsPhase 2, Phase 1, Early Phase 16394
20Analgesics, Non-NarcoticPhase 26501
21Anti-Inflammatory Agents, Non-SteroidalPhase 24443
22AntibodiesPhase 2, Phase 1, Early Phase 16394
23Peripheral Nervous System AgentsPhase 223689
24Gastrointestinal AgentsPhase 28402
25AnalgesicsPhase 211733
26Interleukin 1 Receptor Antagonist ProteinPhase 299
27Antibodies, MonoclonalPhase 2, Phase 1, Early Phase 14039
28Angiogenesis Modulating AgentsPhase 24185
29Angiogenesis InhibitorsPhase 24257
30Complement System ProteinsPhase 2232
31MineralocorticoidsPhase 2367
32Polyestradiol phosphatePhase 21318
33Natriuretic AgentsPhase 21697
34Mineralocorticoid Receptor AntagonistsPhase 2346
35Estradiol valeratePhase 21318979-32-8
36Contraceptives, OralPhase 21327
37Contraceptive AgentsPhase 21967
38EstrogensPhase 22542
39diureticsPhase 21418
40Diuretics, Potassium SparingPhase 21917
41Estradiol 3-benzoatePhase 21318
42Estradiol 17 beta-cypionatePhase 21318
43Drospirenone and ethinyl estradiol combinationPhase 290
44
Phenolapproved, experimentalPhase 149108-95-2996
Synonyms:
Acide carbolique
Acide phenique
Anbesol
Benzenol
Benzophenol
Campho-phenique cold sore gel
Campho-phenique gel
Campho-phenique liquid
Carbolic acid
Carbolic acid liquid
Carbolic oil
Carbolicum acidum
Carbolsaeure
Carbolsaure
Cepastat lozenges
Cuticura pain relieving ointment
Fenol
Fenolo
Fenosmolin
Fenosmoline
Hydroxy-benzene
Hydroxybenzene
IPH
IZAL
Karbolsaeure
Liquefied phenol
Liquid phenol
Liquified phenol
 
Monohydroxy benzene
Monohydroxybenzene
Monophenol
Oxybenzene
PHOH
Paoscle
Phenic
Phenic Acid
Phenic acid
Phenic alcohol
Phenol
Phenol alcohol
Phenol homopolymer
Phenol liquid
Phenol molten
Phenol polymer-bound
Phenol solution
Phenol synthetic
Phenolated water
Phenolated water for disinfection
Phenole
Phenosmolin
Phenyl alcohol
Phenyl hydroxide
Phenylic Acid
Phenylic acid
Phenylic alcohol
Synthetic phenol
Tea polyphenol
45Pharmaceutical SolutionsPhase 18192
46DisinfectantsPhase 1582
47AnestheticsPhase 19596
48Anti-Infective Agents, LocalPhase 11880
49
Triamcinoloneapproved, vet_approved510124-94-731307
Synonyms:
(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
11-beta,16-alpha,17-alpha,21-Tetrahydroxy-9-alpha-fluoro-1,4-pregnadiene-3,20-dione
11.Beta.,16.alpha.,17.alpha., 21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11.beta.,16.alpha.,17.alpha.,21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11β,16α,17α,21-tetrahydroxy-9α-fluoro-1,4-pregnadiene-3,20-dione
124-94-7
4-08-00-03629 (Beilstein Handbook Reference)
83474-03-7
9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-16-alpha-hydroxyprednisolone
9-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.Alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahy
9.Alpha.-Fluoro-11.beta.,16.alpha.,17.alpha., 21-tetrahydroxypregna-1,4-diene-3,20-d
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-16.alpha.-hydroxyprednisolone
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-Fluoro-16alpha-hydroxyprednisolone
9α-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-16α-hydroxyprednisolone
AC-2072
AC1L1LDH
AC1Q5HJC
Adcortyl
Aristocort
Aristocort A
Aristocort Tablets
Aristogel
Aristospan
Azmacort
BPBio1_000154
BRD-K77554836-001-03-3
BRN 2341955
BSPBio_000140
Bio-0662
C21H27FO6
CHEMBL1451
CID31307
CL 19823
Celeste
Cinolone
Cinolone-T
D00385
D014221
DB00620
Delphicort
EINECS 204-718-7
EU-0101179
Fluoxiprednisolone
Fluoxyprednisolone
Flutex
Fougera
HMS1568G22
HMS2090D12
HSDB 3194
Kenacort
Kenacort (TN)
Kenacort-A
Kenacort-AG
Kenacort-Ag
Kenalog
Kenalog in Orabase
Kenalog-10
Kenalog-40
Kenalog-H
LS-698
Ledercort
Lopac0_001179
 
MLS000028542
MLS001066543
MLS002695935
MolPort-002-528-981
Mycolog
NCGC00021580-03
NCGC00021580-04
NCGC00021580-05
NCGC00021580-06
NCGC00021580-07
NCI60_000750
NSC 13397
NSC13397
Nasacort
Nasacort Aq
Nasacort Hfa
Omcilon
Omicilon
Oracort
Oralone
Orion
Polcortolon
Pregna-1,4-diene-3,20-dio
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha)
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy- (8CI)
Prestwick0_000120
Prestwick1_000120
Prestwick2_000120
Prestwick3_000120
Prestwick_438
Rodinolone
S1933_Selleck
SK-Triamcinolone
SMP1_000300
SMR000058333
SPBio_002079
Sk-Triamcinolone
T6376_SIGMA
TRIAMCINOLONE (SEE ALSO TRIAMCINOLONE ACETONIDE (76-25-5) AND TRIAMCINOLONE DIACETATE (67-78-7))
Tiamcinolonum
Tiamcinolonum [INN-Latin]
Tri-Nasal
Triacet
Triacort
Triam-Tablinen
Triamcet
Triamcinalone
Triamcinlon
Triamcinolon
Triamcinolona
Triamcinolona [INN-Spanish]
Triamcinolone (JP15/USP/INN)
Triamcinolone [USAN:INN:BAN:JAN]
Triamcinolone acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Triamcinolonum
Triamcinolonum [INN]
Triatex
Tricortale
Triderm
Trilone
Tristoject
Trymex
UNII-1ZK20VI6TY
Vetalog
Volon
Volon A
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ GQ
ZINC03882036
droxypregna-1,4-diene-3,20-dione
ione
nchembio.2007.53-comp7
triamcinolone
50
Rifampinapproved34813292-46-15458213, 5381226
Synonyms:
1-b]furan-21-yl acetate
13292-46-1
3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin
3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
3-(4-Methylpiperazinyliminomethyl)-rifamycin SV
3-(4-Methylpiperazinyliminomethyl)rifamycin SV
3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV
3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV
3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin
46713_FLUKA
46713_RIEDEL
62534-43-4
8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
8-(4-Methylpiperazinyliminomethyl) rifamycin SV
8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin
8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv
8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv
83907_FLUKA
83907_SIGMA
8CI)
AZT + Rifampin
Abrifam
Archidyn
Arficin
Arzide
BA-41166E
BIDD:PXR0014
BPBio1_000561
BSPBio_000509
Ba 41166
Ba 41166/E
Benemicin
Benemycin
Bio-0621
C06688
C43H58N4O12
CAS-13292-46-1
CCRIS 551
CHEBI:28077
CHEBI:455936
CHEMBL180
CID5381226
CID5388984
CID5458213
CID5702112
CID6604339
CID6708473
CID6842115
CID6912767
CID6913622
CPD001906767
D00211
DB01045
DRG-0109
Dione 21-acetate
Dipicin
DivK1c_000550
Doloresum
EINECS 236-312-0
Eremfat
Famcin
Fenampicin
HMS1569J11
HMS1920P08
HMS2089F12
HMS2092G09
HMS501L12
HSDB 3181
KBio1_000550
KBio2_000919
KBio2_003487
KBio2_006055
KBio3_003018
KBioGR_001780
KBioSS_000919
L-5103
L-5103 Lepetit
LS-7689
MLS000028552
MLS001148237
MLS001333745
MolPort-000-767-051
MolPort-002-513-586
MolPort-003-666-281
MolPort-006-395-891
NCGC00016699-01
NCGC00017365-01
NCGC00018178-01
NCGC00022678-03
NCGC00022678-04
NCGC00022678-05
NCGC00160500-01
 
NCI60_000309
NINDS_000550
NSC 113926
NSC-113926
NSC113926
Piperine & Rifampicin
Prestwick0_000525
Prestwick1_000525
Prestwick2_000525
Prestwick3_000525
Prestwick_833
R-Cin
R/AMP
R0079
R3501_SIAL
R3501_SIGMA
R5777_SIGMA
R7382_SIGMA
RAMP
RFP
RMP
Ramp
Reserpine & Rifampicin
Rf
Rfamipicin
Rifa
Rifadin
Rifadin (TN)
Rifadin I.V
Rifadin I.V.
Rifadin IV
Rifadin Iv
Rifadin, Rimactane, Rifampicin, Rifampin
Rifadine
Rifagen
Rifaldazin
Rifaldazine
Rifaldin
Rifam
Rifamicin AMP
Rifamor
Rifampicin
Rifampicin & EEP
Rifampicin & Propolis
Rifampicin (JP15/INN)
Rifampicin SV
Rifampicin [INN:BAN:JAN]
Rifampicina
Rifampicina [INN-Spanish]
Rifampicine
Rifampicine [French]
Rifampicinum
Rifampicinum [INN-Latin]
Rifampin
Rifampin (USP)
Rifampin [USAN]
Rifamsolin
Rifamycin
Rifamycin AMP
Rifamycin Amp
Rifaprodin
Rifcin
Rifinah
Rifobac
Rifoldin
Rifoldine
Riforal
Rimactan
Rimactane
Rimactane (TN)
Rimactazid
Rimactin
Rimactizid
Rimazid
Rimycin
Rofact
S1764_Selleck
SAM002264646
SMR000058322
SMR000653525
SPBio_002430
SPECTRUM1500529
STK080143
Sinerdol
Spectrum3_001837
Spectrum4_001250
Spectrum5_002018
Spectrum_000439
TNP00313
Tubocin
UNII-VJT6J7R4TR
WLN: V1 WQ A&1 E&1 E1UN- AT6N DNTJ D1
nchembio884-comp4
rifampin

Interventional clinical trials:

(show all 47)
idNameStatusNCT IDPhase
1Safety and Efficacy of Humira (Adalimumab) for Hidradenitis Suppurativa (HS) Peri-Surgically (SHARPS Study)RecruitingNCT02808975Phase 4
2Efficacy and Safety Study of Adalimumab in Treatment of Hidradenitis SuppurativaCompletedNCT01468207Phase 3
3Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis SuppurativaCompletedNCT01468233Phase 3
4Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis SuppurativaCompletedNCT01635764Phase 3
5Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis SuppurativaRecruitingNCT02904902Phase 3
6Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis SuppurativaRecruitingNCT02805595Phase 3
7To Determine the Efficacy of a Laser Device for the Treatment of Hidradenitis SuppurativaTerminatedNCT00367328Phase 3
8To Assess the Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Hidradenitis SuppurativaCompletedNCT00827996Phase 2
9Etanercept in Hidradenitis SuppurativaCompletedNCT00329823Phase 2
10Study to Assess the Safety and Efficacy of Infliximab to Treat Hidradenitis SuppurtativaCompletedNCT00795574Phase 2
11Etanercept for Treatment of HidradenitisCompletedNCT00107991Phase 2
12Efficacy, Safety, and Pharmacokinetics Study of CJM112 in Hidradenitis Suppurativa PatientsCompletedNCT02421172Phase 2
13Anakinra as a Treatment for Hydradenitis SuppurativaCompletedNCT01516749Phase 2
14Anakinra in Hidradenitis SuppurativaCompletedNCT01558375Phase 2
15A Proof of Concept Study to Evaluate the Effectiveness of Ustekinumab in Hidradenitis SuppurativaCompletedNCT01704534Phase 2
16Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis SuppurativaCompletedNCT00918255Phase 2
17MABp1 IN HIDRADENITIS SUPPURATIVA REFRACTORY TO ADALIMUMABCompletedNCT02643654Phase 2
18Single Center Study of Apremilast for the Treatment of Hidradenitis SuppurativaRecruitingNCT02695212Phase 2
19Short-term Safety, Efficacy and Mode of Action of Apremilast in Moderate Suppurative HidradenitisRecruitingNCT03049267Phase 2
20Studying Complement Inhibition in Patients With Moderate to Severe Hidradenitis SuppurativaActive, not recruitingNCT03001622Phase 2
21Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis SuppurativaTerminatedNCT01838499Phase 2
22A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HSTerminatedNCT00722800Phase 2
23Efficacy and Safety of Efalizumab in the Treatment of Moderate-Severe Hydradenitis SuppurativaCompletedNCT00134134Phase 1
24Endoscopic Pilonidal Sinus Treatment With Additional Crystalized PhenolCompletedNCT02277340Phase 1
25An Investigation Into the Efficacy of Provodine Topical Cream as Compared to 10% Benzoyl Peroxide Wash for the Treatment of Hidradenitis Suppurativa.Unknown statusNCT01818167
26Study to Compare Two Treatments for Axillary Hidradenitis Suppurativa: Carbon Dioxide Laser Versus Surgical DeroofingUnknown statusNCT02163746
27Trial Comparing Efficacy of Treatments for Hidradenitis SuppurativaUnknown statusNCT01063270
28Efficacy of Percutaneous Injection of Triamcinolone in the Treatment of Mammillary FistulaUnknown statusNCT01315080
29Study on the Effect of NdYag Laser for the Treatment of Hidradenitis SuppurativaCompletedNCT00494351
30A Small Clinical Study: Photodynamic Therapy to Treat Hidradenitis SuppurativaCompletedNCT00395187
31Activation of a Cutaneous Inflammasome in the Skin of Hidradenitis Suppurativa PatientsCompletedNCT02833909
32Treatment of Hidradenitis Suppurativa Using EtanerceptCompletedNCT00949546
33Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life SettingRecruitingNCT02786576
34Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa SubjectsRecruitingNCT03001115
35A Randomized Controlled Trial Evaluating the Efficacy of Intralesional Triamcinolone in Hidradenitis Suppurativa.RecruitingNCT02781818
36Treatment of Hidradenitis Suppurativa With Eth 755nm Alexandrite LaserRecruitingNCT03054155
37Group Psychotherapy for Patients With Hidradenitis Suppurativa: Effects in Quality of LifeRecruitingNCT02904408
38Low Dose Radiotherapy for Advanced Hidradenitis SuppurativaRecruitingNCT03040804
39Post Marketing Observational Study (PMOS) to Assess Quality of Life in Swedish Hidradenitis Suppurativa (HS) PatientsRecruitingNCT02739828
40Exploratory Trial Evaluating Cosentyx (Secukinumab) for Patients With Moderate-to-Severe Hidradenitis SuppurativaRecruitingNCT03099980Early Phase 1
41Pilot Study on Botulinum Toxin B as Treatment for Hidradenitis SuppurativaRecruitingNCT03103074
42Canadian Humira Post Marketing Observational Epidemiological Study : Assessing Humira Real-life Effectiveness and Impact on HS Burden of IllnessRecruitingNCT02896920
43The Ohio State University Dermatology Biorepository, Molecular Biology and Genetics of Hidradenitis SuppurativaRecruitingNCT03146676
44Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin DiseasesRecruitingNCT01952275
45Quality of Life After Wide Surgical Excision in Patients With Hidradenitis SuppurativaEnrolling by invitationNCT02593604
46Patients With Hidradenitis vs Patients With Psoriasis: Psychological ImpactNot yet recruitingNCT02999698
47Chronic Inflammatory Disease, Lifestyle and Treatment ResponseNot yet recruitingNCT03173144

Search NIH Clinical Center for Hidradenitis


Cochrane evidence based reviews: hidradenitis

Genetic Tests for Hidradenitis

About this section

Anatomical Context for Hidradenitis

About this section

MalaCards organs/tissues related to Hidradenitis:

36
Neutrophil, Skin, Myeloid, Pituitary, Lung, Endothelial, Monocytes

Publications for Hidradenitis

About this section

Articles related to Hidradenitis:

(show top 50)    (show all 720)
idTitleAuthorsYear
1
Factors Contributing to Depression and Chronic Pain in Patients with Hidradenitis Suppurativa: Results from a Single-Center Retrospective Review. (28068657)
2017
2
Interferon-gamma (IFN-I^) is Elevated in Wound Exudate from Hidradenitis Suppurativa. (27819528)
2017
3
Quality of Life and Psychosocial Implications in Patients with Hidradenitis Suppurativa. (28052274)
2017
4
Weekly adalimumab significantly reduces the number of abscesses and inflammatory nodules in patients with moderate to severe hidradenitis suppurativa. (28053204)
2017
5
Response to: 'Autoinflammatory disease damage index (ADDI): a possible newborn also in hidradenitis suppurativa daily practice' by Damiani et al. (28043999)
2017
6
Prevalence and risk of inflammatory bowel disease in patients with hidradenitis suppurativa. (28089682)
2017
7
Hidradenitis suppurativa treated with tetracycline in combination with colchicine: a prospective series of 20 patients. (28054351)
2017
8
Body fat composition in hidradenitis suppurativa: a hospital-based cross-sectional study. (28084004)
2017
9
Population Pharmacokinetics and Immunogenicity of Adalimumab in Adult Patients with Moderate-to-Severe Hidradenitis Suppurativa. (28066879)
2017
10
Pyoderma Gangrenosum, Acne and Suppurative Hidradenitis Syndrome Treated with Granulocyte and Monocyte Adsorption Apheresis. (27384061)
2016
11
Bacterial Biofilm in Chronic Lesions of Hidradenitis Suppurativa. (27564400)
2016
12
Adalimumab: A Review in Hidradenitis Suppurativa. (27665300)
2016
13
Clinical experience of the use of adalimumab in the management of hidradenitis suppurativa. Comparison of response rates with Crohn disease. (28081769)
2016
14
Accelerated wound healing after wide excisions in Hidradenitis Suppurativa using autologous split-thickness skin grafting and platelet-rich plasma. (27611792)
2016
15
Intrinsic defect in keratinocyte function leads to inflammation in Hidradenitis suppurativa. (27206704)
2016
16
Reply to Revuz' Letter Entitled 'Hidradenitis Suppurativa: Terminology'. (27159977)
2016
17
Reduction in pain scores and improvement in depressive symptoms in patients with hidradenitis suppurativa treated with adalimumab in a phase 2, randomized, placebo-controlled trial. (27136622)
2016
18
When inflammation shifts to malignancy: extensive squamous cell carcinoma in a female hidradenitis suppurativa/acne inversa patient. (28036145)
2016
19
Management of hidradenitis suppurativa. (27585997)
2016
20
Hidradenitis suppurativa and perianal Crohn disease: differential diagnosis. (28081767)
2016
21
Combination of oral zinc gluconate and topical triclosan: An anti-inflammatory treatment modality for initial hidradenitis suppurativa. (27554338)
2016
22
Qualitative study shows disease damage matters to patients with hidradenitis suppurativa. (27185436)
2016
23
Hidradenitis suppurativa: A disease of infundibular epidermis, rather than pilosebaceous units? (27542326)
2016
24
Diagnoses of Hidradenitis Suppurativa in the United States, 1979-2012. (27171648)
2016
25
Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: can some factors influence the response to the treatment? (27068603)
2016
26
Hidradenitis suppurativa patients have no increased risk of Alzheimer's disease. (27639074)
2016
27
The Hidradenitis suppurativa patient journey in Italy: current status, unmet needs and opportunities. (27136185)
2016
28
Ustekinumab, another biologic with potential to help patients with hidradenitis suppurativa? (27115586)
2016
29
High Copy Numbers of Beta-Defensin Cluster on 8p23.1 Confer Genetic Susceptibility and Modulate the Physical Course of Hidradenitis Suppurativa/Acne Inversa. (27164300)
2016
30
Hidradenitis suppurativa (HS) and Down syndrome (DS): Increased prevalence and a younger age of hidradenitis symptom onset. (27543219)
2016
31
Epidemiological, clinical and therapeutic aspects in special situations: hidradenitis suppurativa in paediatric patients. (28081770)
2016
32
Management of hidradenitis suppurativa in pregnancy. (28040373)
2016
33
Primary Cutaneous Plasmacytosis: Masquerading as Hidradenitis Suppurativa. (27057027)
2016
34
Hidradenitis suppurativa-acne inversa-like lesions complicating naevus comedonicus: second case supporting the mechanical stress as a triggering factor. (27176082)
2016
35
Recalcitrant Hidradenitis Suppurativa: An Investigation of Demographics, Surgical Management, Bacterial Isolates, Pharmacologic Intervention, and Patient-reported Health Outcomes. (27097631)
2016
36
Regional variation of Hidradenitis suppurativa in the Norwegian Patient Registry (NPR) during 5 years period may describe professional awareness of the disease not changes in prevalens. (27543427)
2016
37
Hidradenitis suppurativa is not associated with the metabolic syndrome based on body type: A cross-sectional study. (27608328)
2016
38
Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: Implications for treatment with anti-IL-17 agents. (28041632)
2016
39
Hidradenitis Suppurativa and Inflammatory Bowel Disease: A Cross-Sectional Study of 3,207 Patients. (27094593)
2016
40
Interventions for hidradenitis suppurativa: an important step towards evidence-based medicine. (27206354)
2016
41
What Heals Hidradenitis Suppurativa: Surgery, Immunosuppression, or Both? (27556765)
2016
42
Discussion: What Heals Hidradenitis Suppurativa: Surgery, Immunosuppression, or Both? (27556766)
2016
43
Hidradenitis Suppurativa and the Association With Hematological Malignancies: A Review of 2 Cases. (27573126)
2016
44
Management of patients with hidradenitis suppurativa. (28081768)
2016
45
Neutrophilic Eccrine Hidradenitis in a Child with Chronic Granulomatous Disease. (27904195)
2016
46
Phenotypic Characterization of Patients with Hidradenitis Suppurativa. (27576734)
2016
47
Management of Hidradenitis Suppurativa in Patients with Metabolic Comorbidities. (27081259)
2016
48
Hidradenitis Suppurativa: Terminology. (27161332)
2016
49
Successful treatment of widespread chronic gluteal hidradenitis suppurativa with combination of recycled skin graft and negative-pressure wound therapy. (27651126)
2016
50
Therapeutic approach to Crohn disease: possible parallels with hidradenitis suppurativa. (28081765)
2016

Variations for Hidradenitis

About this section

Expression for genes affiliated with Hidradenitis

About this section
Search GEO for disease gene expression data for Hidradenitis.

Pathways for genes affiliated with Hidradenitis

About this section

GO Terms for genes affiliated with Hidradenitis

About this section

Cellular components related to Hidradenitis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1gamma-secretase complexGO:00707659.4NCSTN, PSEN1, PSENEN
2cell surfaceGO:00099869.3DSG2, NOD2, PSEN1, TNF
3external side of plasma membraneGO:00098979.1IL12RB1, IL17A, TNF

Biological processes related to Hidradenitis according to GeneCards Suite gene sharing:

(show all 20)
idNameGO IDScoreTop Affiliating Genes
1membrane protein intracellular domain proteolysisGO:003129310.5NCSTN, PSENEN
2beta-amyloid metabolic processGO:005043510.5NCSTN, PSEN1
3epithelial cell proliferationGO:005067310.5NCSTN, PSEN1
4positive regulation of osteoclast differentiationGO:004567210.2IL17A, TNF
5positive regulation of cytokine production involved in inflammatory responseGO:190001710.2IL17A, NOD2
6positive regulation of interleukin-6 productionGO:003275510.2NOD2, TNF
7positive regulation of interleukin-8 productionGO:003275710.2NOD2, TNF
8positive regulation of NIK/NF-kappaB signalingGO:190122410.2NOD2, TNF
9amyloid precursor protein catabolic processGO:004298710.2NCSTN, PSEN1, PSENEN
10amyloid precursor protein metabolic processGO:004298210.2NCSTN, PSEN1, PSENEN
11beta-amyloid formationGO:003420510.2NCSTN, PSEN1, PSENEN
12membrane protein ectodomain proteolysisGO:000650910.1NCSTN, PSEN1, PSENEN
13Notch receptor processingGO:000722010.1NCSTN, PSEN1, PSENEN
14Notch signaling pathwayGO:000721910.1NCSTN, PSEN1, PSENEN
15positive regulation of catalytic activityGO:004308510.0NCSTN, PSEN1, PSENEN
16positive regulation of interferon-gamma productionGO:00327299.9IL12RB1, TNF
17positive regulation of apoptotic processGO:00430659.7NCSTN, PSEN1, PSENEN, TNF
18cornificationGO:00702689.5DSG2, KRT10, KRT14
19keratinizationGO:00314249.5DSG2, KRT10, KRT14
20protein processingGO:00164859.4NCSTN, PSEN1, PSENEN

Sources for Hidradenitis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet